Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

FENC Stock Forecast, Price Targets, Chart, Dividends & Analysis

Fennec Pharmaceuticals Inc. logo

Fennec Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

4.19
 
USD
  
-0.07
  
(-1.64%)
Previous close: 4.26  Open: 4.23  Bid: 4.0  Ask: 4.24
52 week range    
4.09   
   11.92
Mkt Cap: 123 M  Avg Vol (90 Days): 86,240
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Friday 11th October 2024

Stock Rankings

34
MarketXLS Rank
45
Value
7
Technical
52
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0.0085

OTLC

OVAT-CA

Financials

FENC Income Statement

Annual
Invalid dateDec-22Dec-23
Basic EPS from continuing operations-0.9-0.6
Basic EPS total-0.9-0.6
Basic weighted shares outstanding26 M27 M
Cost of sales86000.01 M
Depreciation unreconciled149000.0287000.0
DepreciationAndAmortization149000.0287000.0
Diluted EPS total-0.9-0.6
Diluted normalized net income/share-0.9-0.6
Diluted weighted shares outstanding26 M27 M
GeneralAndAdministrativeExpense18 M21 M
Gross operating profit1 M20 M
Income before tax-24 M-16 M
Interest income195000.0441000.0
InterestExpenseNonOperating978000.03 M
Net income from total operations-24 M-16 M
NetIncomeCommonStockholders-24 M-16 M
NetIncomeContinuousOperations-24 M-16 M
NetNonOperatingInterestIncomeExpense-783000.0-3 M
Normalized income-17 M-12 M
Operating income-23 M-13 M
Operating income before depreciation (EBITDA)-23 M-12 M
OperatingExpense24 M33 M
Other income net184000.039000.0
OtherCostofRevenue86000.01 M
OtherGandA18 M21 M
Research & development expense4 M56000.0
ResearchExpense4 M56000.0
Revenue per share149000.0287000.0
Selling Gen & administrative expense21 M33 M
SellingAndMarketingExpense3 M12 M
Total Income available for interest expense (EBIT)-23 M-13 M
Total net income-24 M-16 M
Total ordinary shares27 M27 M
Total revenues2 M21 M
TotalExpenses24 M34 M
TotalRevenue2 M21 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University